Wenming Feng1, Huihui Guo2, Hui Gong2, Tao Xue2, Xiang Wang2, Chengwu Tang1, Yongqiang Xu1, Chuang Dai1, Ying Bao1, Ting Zhang3, Ge Cui4. 1. Department of Surgery, The First Affiliated Hospital of Huzhou University, Huzhou, China. 2. Central Laboratory, The First Affiliated Hospital of Huzhou University, Huzhou, China. 3. Department of Pathology, School of Medicine and Nursing Sciences, Huzhou University, Huzhou Central Hospital, Huzhou, China. 4. Department of Pathology, The First Affiliated Hospital of Huzhou University, Huzhou, China.
Abstract
BACKGROUND: Epidemiological studies have found that hyperglycemia, is an independent risk factor for colorectal cancer (CRC), increasing colon cancer incidence and affecting the recurrence, metastasis, and prognosis in colon cancer patients. However, the intercorrelation between hyperglycemia and CRC risk is still unknown, In the present study, we sought to determine whether gene markers, which act in CRC with hyperglycemia, are silenced in CRC without hyperglycemia. METHODS: In order to characterize the mechanism of functional genes associated with CRC with hyperglycemia, A total 24 CRC and matched controls were sequenced. Through bioinformatics analysis includes differential expression analysis, functional enrichment, new isoform prediction and alternative splicing event identification to found biomarker genes related to CRC development. RESULTS: CRC patients with hyperglycemia were compared with patients without hyperglycemia, and we found that 21 genes were upregulated and 27 were downregulated. Further study showed that these genes are possibly of key genes involved in CRC development with hyperglycemia, such as mannan-binding lectin-associated serine protease 3 (MASP3), which has an immunological role in the activation of the complement system. Based on our comprehensive analysis, a cis-regulatory network for hyperglycemic CRC was reconstructed. CONCLUSIONS: Protein-protein interactions revealed the mechanisms of molecules involved in the interaction of hyperglycemia and cancer development. Our results provide further information on the metabolic pathway interaction with cancer pathways and elucidated the mechanisms of hyperglycemic factors function in cancer development from a transcriptomic perspective. 2021 Journal of Gastrointestinal Oncology. All rights reserved.
BACKGROUND: Epidemiological studies have found that hyperglycemia, is an independent risk factor for colorectal cancer (CRC), increasing colon cancer incidence and affecting the recurrence, metastasis, and prognosis in colon cancer patients. However, the intercorrelation between hyperglycemia and CRC risk is still unknown, In the present study, we sought to determine whether gene markers, which act in CRC with hyperglycemia, are silenced in CRC without hyperglycemia. METHODS: In order to characterize the mechanism of functional genes associated with CRC with hyperglycemia, A total 24 CRC and matched controls were sequenced. Through bioinformatics analysis includes differential expression analysis, functional enrichment, new isoform prediction and alternative splicing event identification to found biomarker genes related to CRC development. RESULTS: CRC patients with hyperglycemia were compared with patients without hyperglycemia, and we found that 21 genes were upregulated and 27 were downregulated. Further study showed that these genes are possibly of key genes involved in CRC development with hyperglycemia, such as mannan-binding lectin-associated serine protease 3 (MASP3), which has an immunological role in the activation of the complement system. Based on our comprehensive analysis, a cis-regulatory network for hyperglycemic CRC was reconstructed. CONCLUSIONS: Protein-protein interactions revealed the mechanisms of molecules involved in the interaction of hyperglycemia and cancer development. Our results provide further information on the metabolic pathway interaction with cancer pathways and elucidated the mechanisms of hyperglycemic factors function in cancer development from a transcriptomic perspective. 2021 Journal of Gastrointestinal Oncology. All rights reserved.
Entities:
Keywords:
Transcriptome; colorectal cancer (CRC); hyperglycemia
Authors: Cole Trapnell; Adam Roberts; Loyal Goff; Geo Pertea; Daehwan Kim; David R Kelley; Harold Pimentel; Steven L Salzberg; John L Rinn; Lior Pachter Journal: Nat Protoc Date: 2012-03-01 Impact factor: 13.491
Authors: Cole Trapnell; David G Hendrickson; Martin Sauvageau; Loyal Goff; John L Rinn; Lior Pachter Journal: Nat Biotechnol Date: 2012-12-09 Impact factor: 54.908
Authors: Melissa S DeRycke; Shanaka R Gunawardena; Sumit Middha; Yan W Asmann; Daniel J Schaid; Shannon K McDonnell; Shaun M Riska; Bruce W Eckloff; Julie M Cunningham; Brooke L Fridley; Daniel J Serie; William R Bamlet; Mine S Cicek; Mark A Jenkins; David J Duggan; Daniel Buchanan; Mark Clendenning; Robert W Haile; Michael O Woods; Steven N Gallinger; Graham Casey; John D Potter; Polly A Newcomb; Loïc Le Marchand; Noralane M Lindor; Stephen N Thibodeau; Ellen L Goode Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-05-01 Impact factor: 4.254
Authors: Jan Mauer; Bhagirath Chaurasia; Julia Goldau; Merly C Vogt; Johan Ruud; Khoa D Nguyen; Sebastian Theurich; A Christine Hausen; Joel Schmitz; Hella S Brönneke; Emma Estevez; Tamara L Allen; Andrea Mesaros; Linda Partridge; Mark A Febbraio; Ajay Chawla; F Thomas Wunderlich; Jens C Brüning Journal: Nat Immunol Date: 2014-03-30 Impact factor: 25.606
Authors: S Valpione; G Gremel; P Mundra; P Middlehurst; E Galvani; M R Girotti; R J Lee; G Garner; N Dhomen; P C Lorigan; R Marais Journal: Eur J Cancer Date: 2017-11-23 Impact factor: 9.162